20-18542358-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006363.6(SEC23B):​c.1467C>G​(p.His489Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 1,614,028 control chromosomes in the GnomAD database, including 11,624 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1301 hom., cov: 33)
Exomes 𝑓: 0.11 ( 10323 hom. )

Consequence

SEC23B
NM_006363.6 missense

Scores

3
7
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.0430

Publications

35 publications found
Variant links:
Genes affected
SEC23B (HGNC:10702): (SEC23 homolog B, COPII coat complex component) The protein encoded by this gene is a member of the SEC23 subfamily of the SEC23/SEC24 family, which is involved in vesicle trafficking. The encoded protein has similarity to yeast Sec23p component of COPII. COPII is the coat protein complex responsible for vesicle budding from the ER. The function of this gene product has been implicated in cargo selection and concentration. Multiple alternatively spliced transcript variants have been identified in this gene. [provided by RefSeq, Feb 2010]
SEC23B Gene-Disease associations (from GenCC):
  • congenital dyserythropoietic anemia type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine, G2P
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 7
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital dyserythropoietic anemia
    Inheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026350617).
BP6
Variant 20-18542358-C-G is Benign according to our data. Variant chr20-18542358-C-G is described in ClinVar as Benign. ClinVar VariationId is 95382.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEC23B
NM_006363.6
MANE Select
c.1467C>Gp.His489Gln
missense
Exon 13 of 20NP_006354.2
SEC23B
NM_001172745.3
c.1467C>Gp.His489Gln
missense
Exon 13 of 20NP_001166216.1
SEC23B
NM_032985.6
c.1467C>Gp.His489Gln
missense
Exon 13 of 20NP_116780.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEC23B
ENST00000650089.1
MANE Select
c.1467C>Gp.His489Gln
missense
Exon 13 of 20ENSP00000497473.1
SEC23B
ENST00000336714.8
TSL:1
c.1467C>Gp.His489Gln
missense
Exon 13 of 20ENSP00000338844.3
SEC23B
ENST00000377465.6
TSL:1
c.1467C>Gp.His489Gln
missense
Exon 13 of 20ENSP00000366685.1

Frequencies

GnomAD3 genomes
AF:
0.125
AC:
19043
AN:
152160
Hom.:
1302
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.159
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.165
Gnomad EAS
AF:
0.160
Gnomad SAS
AF:
0.0411
Gnomad FIN
AF:
0.131
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.145
GnomAD2 exomes
AF:
0.128
AC:
32275
AN:
251452
AF XY:
0.122
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.207
Gnomad ASJ exome
AF:
0.144
Gnomad EAS exome
AF:
0.169
Gnomad FIN exome
AF:
0.129
Gnomad NFE exome
AF:
0.121
Gnomad OTH exome
AF:
0.128
GnomAD4 exome
AF:
0.114
AC:
167281
AN:
1461750
Hom.:
10323
Cov.:
33
AF XY:
0.112
AC XY:
81585
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.117
AC:
3911
AN:
33478
American (AMR)
AF:
0.204
AC:
9131
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.149
AC:
3884
AN:
26136
East Asian (EAS)
AF:
0.150
AC:
5942
AN:
39696
South Asian (SAS)
AF:
0.0456
AC:
3936
AN:
86258
European-Finnish (FIN)
AF:
0.128
AC:
6856
AN:
53408
Middle Eastern (MID)
AF:
0.138
AC:
797
AN:
5766
European-Non Finnish (NFE)
AF:
0.113
AC:
125910
AN:
1111894
Other (OTH)
AF:
0.114
AC:
6914
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
8340
16679
25019
33358
41698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4514
9028
13542
18056
22570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.125
AC:
19045
AN:
152278
Hom.:
1301
Cov.:
33
AF XY:
0.126
AC XY:
9368
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.114
AC:
4741
AN:
41548
American (AMR)
AF:
0.183
AC:
2801
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.165
AC:
574
AN:
3472
East Asian (EAS)
AF:
0.160
AC:
830
AN:
5174
South Asian (SAS)
AF:
0.0412
AC:
199
AN:
4832
European-Finnish (FIN)
AF:
0.131
AC:
1387
AN:
10612
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.118
AC:
8015
AN:
68026
Other (OTH)
AF:
0.144
AC:
304
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
885
1770
2656
3541
4426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.110
Hom.:
792
Bravo
AF:
0.132
TwinsUK
AF:
0.118
AC:
439
ALSPAC
AF:
0.109
AC:
421
ESP6500AA
AF:
0.121
AC:
531
ESP6500EA
AF:
0.118
AC:
1012
ExAC
AF:
0.124
AC:
15100
Asia WGS
AF:
0.0990
AC:
344
AN:
3478
EpiCase
AF:
0.121
EpiControl
AF:
0.125

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29300242, 29031773)

Nov 14, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 09, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital dyserythropoietic anemia, type II Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital dyserythropoietic anemia, type II;C4225179:Cowden syndrome 7 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cowden syndrome 7 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T
Eigen
Benign
0.17
Eigen_PC
Benign
0.091
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.96
D
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Pathogenic
3.2
M
PhyloP100
0.043
PrimateAI
Uncertain
0.72
T
PROVEAN
Pathogenic
-7.1
D
REVEL
Uncertain
0.41
Sift
Uncertain
0.018
D
Sift4G
Uncertain
0.013
D
Polyphen
0.45
B
Vest4
0.24
MutPred
0.28
Gain of MoRF binding (P = 0.0941)
MPC
0.39
ClinPred
0.11
T
GERP RS
0.58
PromoterAI
-0.013
Neutral
Varity_R
0.84
gMVP
0.75
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2273526; hg19: chr20-18523002; COSMIC: COSV52719183; COSMIC: COSV52719183; API